Published in Epilepsy Res on January 17, 1989
Rates of mitochondrial DNA evolution in sharks are slow compared with mammals. Nature (1992) 2.82
Structural biology and phylogenetic estimation. Nature (1997) 1.34
A double-blind comparison of paroxetine and placebo in the treatment of depressed patients in a psychiatric outpatient clinic. Acta Psychiatr Scand Suppl (1989) 1.17
A two-year double-blind crossover trial of the prophylactic effect of methylene blue in manic-depressive psychosis. Biol Psychiatry (1986) 1.08
Lithium in non-manic-depressives: antiaggressive effect and red blood cell lithium values. Br J Psychiatry (1975) 1.08
Defective genetic control of sodium-pump density in manic depressive psychosis. Psychol Med (1981) 1.08
Erythrocyte membrane cation carrier in depressive illness. Psychol Med (1973) 1.03
Hydrophobicity and phylogeny. Nature (1995) 1.02
Sleep patterns in depressive states. Br J Med Psychol (1972) 1.01
Rapid flux in plant genomes. Nat Genet (1998) 0.99
A controlled trial of methylene blue in severe depressive illness. Biol Psychiatry (1987) 0.97
Controlled studies of the acute antidepressant effects of lithium. Br J Psychiatry (1979) 0.90
Vitamin D intoxication, with hypernatraemia, potassium and water depletion, and mental depression. Br Med J (1968) 0.90
Short-cycle manic depressive psychosis in mental defectives: a clinical and physiological study. J Ment Defic Res (1976) 0.90
A biochemical study of short-cycle manic-depressive psychosis in mental defectives. Br J Psychiatry (1976) 0.88
Erythrocyte membrane cation carrier in mania. Psychol Med (1976) 0.88
A double-blind trial of long-term lithium therapy in mental defectives. Br J Psychiatry (1974) 0.88
Tissue vanadium levels in manic-depressive psychosis. Psychol Med (1984) 0.87
Erythrocyte membrane cation carrier, relapse rate of manic-depressive illness and response to lithium. Psychol Med (1976) 0.87
Plasma vanadium concentration in manic-depressive illness. Psychol Med (1982) 0.86
Lithium and erythrocyte membrane cation carrier studies in normal and manic depressive subjects. Psychol Med (1977) 0.86
Emotional disturbance following childbirth: clinical findings and urinary excretion of cyclic AMP (adenosine 3'5'cyclic monophosphate). Psychol Med (1979) 0.85
Elevated vanadium content of hair and mania. Biol Psychiatry (1984) 0.84
Plasma magnesium and calcium levels in depressive psychosis. Br J Psychiatry (1972) 0.84
Trial of digoxin in mania. Lancet (1975) 0.82
Methylene blue in mania. Biol Psychiatry (1988) 0.82
Plasma tryptophan concentration in depressive illness and mania. Br J Psychiatry (1976) 0.82
Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients. Br J Psychiatry (1986) 0.81
The effect of digoxin on the response to lithium therapy in mania. Psychol Med (1982) 0.81
Methylene blue. A possible treatment for manic depressive psychosis. J Affect Disord (1983) 0.80
Erythrocyte membrane cation carrier in manic-depressive psychosis. Psychol Med (1980) 0.80
Lithium therapy and erythrocyte membrane cation carrier. Psychopharmacologia (1974) 0.80
Catecholamine metabolism in affective disorders: excretion of 3-methoxy-4-hydroxymandelic acid in depressive states. Can Psychiatr Assoc J (1972) 0.79
Plasma concentrations of protriptyline and clinical effects in depressed women. Br J Psychiatry (1976) 0.79
Possible explanation for therapeutic action of lithium, and a possible substitute (methylene-blue) Lancet (1981) 0.79
Changes in erythrocyte sodium and potassium on recovery from a depressive illness. Br J Psychiatry (1971) 0.79
Phylogenetic inference from conserved sites alignments. J Exp Zool (1999) 0.78
Lithium side effects in a routine lithium clinic. Br J Psychiatry (1979) 0.78
Changes in the erythrocyte sodium pump with age. Gerontology (1977) 0.77
A double blind placebo controlled trial of ascorbic acid in obesity. Nutr Health (1985) 0.77
Reversal of vanadate-induced inhibition of Na-K ATPase. A possible explanation of the therapeutic effect of carbamazepine in affective illness. J Affect Disord (1985) 0.77
Vanadium: a possible aetiological factor in manic depressive illness. Psychol Med (1981) 0.77
Prediction of clinical course of bipolar manic depressive illness treated with lithium. Psychol Med (1980) 0.77
Factor VIII-related antigen and procoagulant activity in manic-depressive patients. J Affect Disord (1983) 0.76
Unpleasant taste--a neglected symptom in depression. J Affect Disord (1989) 0.76
Cation transport in lymphoblastoid cell lines established from bipolar manic-depressive patients. J Affect Disord (1989) 0.76
Erythrocyte sodium and potassium in depre- ssive illness. J Psychosom Res (1970) 0.76
Vanadium and manic depressive psychosis. Nutr Health (1984) 0.76
A double-blind, placebo controlled, crossover trial of carbamazepine in overactive, severely mentally handicapped patients. Psychol Med (1981) 0.76
Pharmacokinetic aspects of protriptyline plasma levels. Eur J Clin Pharmacol (1977) 0.76
The therapeutic effect of ascorbic acid and EDTA in manic-depressive psychosis: double-blind comparisons with standard treatments. Psychol Med (1984) 0.76
Some biochemical findings during pregnancy and after delivery in relation to mood change. Psychol Med (1982) 0.75
Tyramine conjugation and antidepressants. Lancet (1989) 0.75
Bromocriptine in mania--a placebo-controlled double-blind trial. Br Med J (1980) 0.75
The effect of mianserin on urinary catecholamine excretion in psychiatric patients. Br J Clin Pharmacol (1981) 0.75
Profound hypothermia on combined lithium carbonate and diazepam treatment. Br Med J (1977) 0.75
A simple method for the determination of protriptyline in plasma. Clin Chim Acta (1973) 0.75
Incorporation of inositol into the phosphoinositides of lymphoblastoid cell lines established from bipolar manic-depressive patients. J Affect Disord (1990) 0.75
New approaches to the treatment of manic depressive illness. Neuropharmacology (1980) 0.75
The antidepressant properties of mianserin and its effect on sleep. Acta Psychiatr Belg (1979) 0.75
Conflicting phylogenetic patterns caused by molecular mechanisms in mitochondrial DNA sequences. Syst Biol (1998) 0.75
Changes in erythrocyte membrane cation carrier with age in women. Gerontology (1980) 0.75
A double-blind out-patient trial of indalpine vs mianserin. Br J Psychiatry (1985) 0.75
Depot injections for affective disorders. Br J Psychiatry (1980) 0.75
Cyclic AMP levels in blood cells from a short-cycle manic-depressive subject. Br J Psychiatry (1980) 0.75
Catalysis of the reduction of vanadate by psychotropic drugs. Neuropharmacology (1983) 0.75
Erythrocyte ouabain binding in dementia. Gerontology (1983) 0.75
The plasma control of erythrocyte sodium and potassium metabolism in depressive illness. J Psychosom Res (1970) 0.75
Sodium and potassium transport in depressive illness. J Physiol (1972) 0.75
Methysergide in mania: a double-blind comparison with thioridazine. Psychol Med (1972) 0.75
Indoleamine metabolism in affective disorders: excretion of tryptamine, indoleacetic acid and 5-hydroxy-indoleacetic acid in depressive states. J Psychosom Res (1972) 0.75
Caesium levels in manic depressive psychosis. J Affect Disord (1989) 0.75
Urinary excretion of adenosine 3' :5'-cyclic monophosphate in depressive illness. Br J Psychiatry (1974) 0.75
A study of plasma tryptophan and tyrosine in mania. Postgrad Med J (1977) 0.75
Trace elements in manic depressive psychosis. J Affect Disord (1985) 0.75
Clomipramine and flupenthixol--additive antidepressants? Br J Psychiatry (1987) 0.75
Whole blood adenosine triphosphate in manic-depressive illness. Br J Psychiatry (1976) 0.75
Methylene blue excretion in depression. Biol Psychiatry (1989) 0.75
Letter: Lithium in manic-depressive illness. Lancet (1974) 0.75
Vanadium and affective disorders. Biol Psychiatry (1983) 0.75
The relationship between age and sodium metabolism in human erythrocytes. Gerontologia (1970) 0.75
A model for phylogenetic inference using structural and chemical covariates. Pac Symp Biocomput (2001) 0.75
A controlled trial of L-tryptophan in mania. Br J Psychiatry (1978) 0.75